QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avenue-therapeutics-q2-eps-011-up-from-643-yoy-sales-1404m

Avenue Therapeutics (OTC:ATXI) reported quarterly earnings of $0.11 per share. This is a 101.71 percent increase over losses of...

 venue-therapeutics-files-for-mixed-shelf-of-upto-35m

- SEC Filing

 avenue-therapeutics-q3-eps-192-misses-094-estimate

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(1.92) per share which missed the analyst consensus estimate of...

 avenue-therapeutics-q2-eps-643-misses-105-estimate

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(6.43) per share which missed the analyst consensus estimate of...

 avenue-therapeutics-q1-eps-1540-misses-900-estimate

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(15.40) per share which missed the analyst consensus estimate o...

 avenue-therapeutics-may-offer-shares-of-common-stock-having-offering-price-of-up-to-39m-from-time-to-time-through-agent

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION